Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Q-LAMP Method Represents a Valid and Rapid Alternative for the Detection of the BCR-ABL1 Rearrangement in Philadelphia-Positive Leukemias.
Stella S, Gottardi EM, Favout V, Barragan Gonzalez E, Errichiello S, Vitale SR, Fava C, Luciano L, Stagno F, Grimaldi F, Pironi L, Sargas Simarro C, Vigneri P, Izzo B. Stella S, et al. Among authors: vitale sr. Int J Mol Sci. 2019 Dec 4;20(24):6106. doi: 10.3390/ijms20246106. Int J Mol Sci. 2019. PMID: 31817063 Free PMC article.
Diagnosis of blastic phase of chronic myeloid leukemia.
Stagno F, Vigneri P, Cupri A, Vitale SR, Di Raimondo F. Stagno F, et al. Among authors: vitale sr. Acta Haematol. 2012;127(4):198. doi: 10.1159/000337267. Epub 2012 Mar 21. Acta Haematol. 2012. PMID: 22441204 No abstract available.
Infliximab therapy in hematologic malignancies: handle with care.
Stagno F, Vigneri P, Cupri A, Vitale SR, Di Raimondo F. Stagno F, et al. Among authors: vitale sr. Haematologica. 2012 Aug;97(8):e26; author reply e27. doi: 10.3324/haematol.2012.067934. Haematologica. 2012. PMID: 22855845 Free PMC article. No abstract available.
Roles of Interferon Regulatory Factors in Chronic Myeloid Leukemia.
Manzella L, Tirrò E, Pennisi MS, Massimino M, Stella S, Romano C, Vitale SR, Vigneri P. Manzella L, et al. Among authors: vitale sr. Curr Cancer Drug Targets. 2016;16(7):594-605. doi: 10.2174/1568009616666160105105857. Curr Cancer Drug Targets. 2016. PMID: 26728039 Review.
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib.
Stella S, Zammit V, Vitale SR, Pennisi MS, Massimino M, Tirrò E, Forte S, Spitaleri A, Antolino A, Siracusa S, Accurso V, Mannina D, Impera S, Musolino C, Russo S, Malato A, Mineo G, Musso M, Porretto F, Martino B, Di Raimondo F, Manzella L, Vigneri P, Stagno F. Stella S, et al. Among authors: vitale sr. Int J Mol Sci. 2019 May 6;20(9):2226. doi: 10.3390/ijms20092226. Int J Mol Sci. 2019. PMID: 31064152 Free PMC article.
46 results